Legal & General Group Plc

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 764068 London, X0

Back to VRTX Full portfolio

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$928,892,550

+$55,565,695 QoQ

Shares Held

1,870,015

-4.4% QoQ

Ownership

0.738%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#26

of 1,732 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 92% Shared 0% None 8%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. VRTX ranks #1 (28.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,870,015	$928,892,550
2	REGN	Regeneron Pharmaceuticals, Inc.	759,971	$473,872,316
3	ALNY	Alnylam Pharmaceuticals, Inc.	924,561	$278,320,596
4	RPRX	Royalty Pharma plc	3,800,504	$213,094,258
5	INCY	Incyte Corp	1,605,980	$182,053,892
6	ARGX	Argenx SE	177,164	$164,367,443
7	INSM	INSMED Inc	826,431	$88,114,072
8	RVMD	Revolution Medicines, Inc.	381,366	$71,422,223

All Filings in VRTX

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$928,892,550	1,870,015	-4.4%	Shares	Defined	2026-08-14
2026-03-31	$873,326,855	1,955,764	-0.7%	Shares	Defined	2026-05-08
2025-12-31	$893,166,801	1,970,105	+0.9%	Shares	Defined	2026-02-09
2025-09-30	$764,597,595	1,952,297	+3.3%	Shares	Defined	2025-11-13
2025-06-30	$841,328,720	1,889,777	-0.2%	Shares	Defined	2025-08-12
2025-03-31	$918,331,014	1,894,169	+0.5%	Shares	Defined	2025-05-15
2024-12-31	$758,748,412	1,884,153	-1.1%	Shares	Defined	2025-02-13
2024-09-30	$886,122,503	1,905,312	-3.4%	Shares	Defined	2025-02-28
2024-06-30	$924,491,609	1,972,375	-2.6%	Shares	Defined	2025-05-29
2024-03-31	$846,748,643	2,025,666	-1.7%	Shares	Defined	2025-05-29
2023-12-31	$838,846,457	2,061,605	+1.0%	Shares	Defined	2025-05-29
2023-09-30	$709,514,090	2,040,358	-4.2%	Shares	Defined	2023-11-14
2023-06-30	$749,187,885	2,128,919	+2.0%	Shares	Defined	2023-08-14
2023-03-31	$657,340,307	2,086,331	+2.6%	Shares	Defined	2023-05-15
2022-12-31	$587,194,855	2,033,364	-4.9%	Shares	Defined	2023-02-14
2022-09-30	$619,064,894	2,138,098	-2.8%	Shares	Defined	2022-11-14
2022-06-30	$620,149,059	2,200,749	+7.0%	Shares	Defined	2022-08-22
2022-03-31	$536,848,955	2,057,129	+8.3%	Shares	Defined	2022-05-16
2021-12-31	$416,942,222	1,898,644	-8.2%	Shares	Defined	2022-02-14
2021-09-30	$375,175,103	2,068,334	+6.1%	Shares	Defined	2021-11-15
2021-06-30	$392,988,361	1,949,057	+14.1%	Shares	Defined	2021-08-12
2021-03-31	$367,117,430	1,708,397	-0.7%	Shares	Defined	2021-05-17
2020-12-31	$406,582,317	1,720,328	+2.0%	Shares	Defined	2021-02-12
2020-09-30	$458,768,195	1,685,904	+2.9%	Shares	Defined	2020-11-13
2020-06-30	$475,743,188	1,638,742	+3.4%	Shares	Defined	2020-08-14
2020-03-31	$377,103,635	1,584,802	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.